Vivek Subbiah/LinkedIn
Jan 21, 2025, 15:31
Vivek Subbiah: Delighted to work with an amazing crew at Sarah Cannon Research Institute
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on LinkedIn:
“Such a delight to work with an amazing crew at Sarah Cannon Research Institute who tirelessly work behind the scenes to bring cutting-edge clinical trials to patients with cancer.
Your dedication and hard work, on MLK Day, are truly commendable. Incredible work.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 13:00
Feb 21, 2025, 12:53
Feb 21, 2025, 12:41
Feb 21, 2025, 12:39
Feb 21, 2025, 11:36
Feb 21, 2025, 11:29